| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |